<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03014921</url>
  </required_header>
  <id_info>
    <org_study_id>2016-00324</org_study_id>
    <nct_id>NCT03014921</nct_id>
  </id_info>
  <brief_title>Impact of Iron Injection on Blood Donation</brief_title>
  <acronym>FERDOP</acronym>
  <official_title>Effet de l'Injection de Fer Sur la Donation Sanguine, étude randomisée et contrôlée</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nicolas Leuenberger</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Centre Hospitalier Universitaire Vaudois</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Universitaire Vaudois</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trial study and compare in blood and urinary matrices the impact of an iron injection on&#xD;
      proteins involved in iron metabolism during a blood donation. The goal is to study the impact&#xD;
      of an iron injection on detection markers of a blood donation in the anti-doping field&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study aim to investigate the impact of an iron injection on the proteins involved in&#xD;
      iron metabolism during blood donation and to compare the blood and urinary matrix. A&#xD;
      messenger RNA profiling will be performed as well. The goal is to investigate the impact of&#xD;
      iron injection on the markers of blood donation detection in the anti-doping field.&#xD;
&#xD;
      The study will take place over a period of 8 weeks.&#xD;
&#xD;
      Volunteers will be randomly assigned to two groups. Randomization will be provided by a&#xD;
      software made for this purpose. An injection of 500 mg of iron in 250mL of saline solution or&#xD;
      a placebo injection containing only the saline solution will be performed. Standard blood&#xD;
      sampling (in the arm) and finger prick blood sampling will be carried out. After that, 500 mL&#xD;
      blood donation will be done. Standard blood sampling and finger prick blood sampling will be&#xD;
      performed before and after the donation.&#xD;
&#xD;
      The study will be done in &quot;simple blind&quot;, meaning that volunteers will not know if they get&#xD;
      iron or saline solution.&#xD;
&#xD;
      On the days of iron or saline solution injection and blood donation, blood sampling will be&#xD;
      done up to 12 hours after the injection. After that, blood sampling will be scheduled up to&#xD;
      30 days after blood donation at a rate of once a day (except for the weekends).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>December 2016</start_date>
  <completion_date type="Anticipated">April 2017</completion_date>
  <primary_completion_date type="Anticipated">March 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Serum ferritin level variations due to iron injection or blood donation</measure>
    <time_frame>8 weeks</time_frame>
    <description>measurements will be done in ug/l</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hemoglobin level variations due to iron injection or blood donation</measure>
    <time_frame>8 weeks</time_frame>
    <description>measurements will be done in g/dL</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reticulocyte% variations due to iron injection or blood donation</measure>
    <time_frame>8 weeks</time_frame>
    <description>measurements will be done in %</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">19</enrollment>
  <condition>Iron Deficiency</condition>
  <arm_group>
    <arm_group_label>placebo injection group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>saline solution injection as placebo</description>
  </arm_group>
  <arm_group>
    <arm_group_label>iron injection group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>iron injection</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>iron injection</intervention_name>
    <description>Injection of a 250mL saline solution added with 500mg of iron (Ferinject)</description>
    <arm_group_label>iron injection group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>saline solution injection</intervention_name>
    <description>Injection of a 250mL saline solution</description>
    <arm_group_label>placebo injection group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male between 20 and 35 yo&#xD;
&#xD;
          -  BMI between 18 and 30&#xD;
&#xD;
          -  Ferritin &lt; 50ug/l&#xD;
&#xD;
          -  Transferrin saturation &lt; 20 if ferritin between 20 and 50ug/l&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  high level athlete&#xD;
&#xD;
          -  blood donation within 6 months before the study&#xD;
&#xD;
          -  liver disorder&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>January 2017</verification_date>
  <study_first_submitted>December 23, 2016</study_first_submitted>
  <study_first_submitted_qc>January 6, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 9, 2017</study_first_posted>
  <last_update_submitted>January 6, 2017</last_update_submitted>
  <last_update_submitted_qc>January 6, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 9, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Centre Hospitalier Universitaire Vaudois</investigator_affiliation>
    <investigator_full_name>Nicolas Leuenberger</investigator_full_name>
    <investigator_title>PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anemia, Iron-Deficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

